P and F Program

项目总结-试点和可行性计划 芝加哥DRTC的试点和可行性计划(P&F)已经为165多个项目提供了175多笔赠款 该委员会自1977年成立以来一直在调查这一问题。在过去10年报告所述期间，46项申请获得资助， 其中27人来自芝加哥大学以外附属机构的调查人员。在这46人中，有34人 获奖者(75%)在过去10年中获得了P&F奖的外部资金，其中包括20个R01 奖励，投资回报近10倍。因此，P&F计划既协助调查人员 整个芝加哥地区的糖尿病相关研究，也是获得新的， 来自NIH和其他外部来源的独立资金。P&F计划的总体目标是提供 向新成立的调查人员提供初步支持，并从 糖尿病研究的其他领域。每年都会向总部位于芝加哥的所有机构征求建议书 糖尿病研究项目。所有提案都由一名内部审查员和两名外部审查员进行评估。优先性 然后向指导委员会提交分数和书面审查，并做出资金决定。一个 对于那些在以下方面取得重大书面进展的调查人员来说，第二年的资助是可能的 他们提出的研究。所有P&F奖助金获得者都被要求参加，并强烈鼓励他们提交他们的 在芝加哥大学举行的一年一度的芝加哥糖尿病日或糖尿病与肥胖研究中的发现 伊利诺伊大学芝加哥分校的一天。绝大多数P&F赠款获得者仍患有糖尿病 研究。P&F计划的目标是： 1.资助P&F研究，包括糖尿病病因的基础、翻译和临床研究 及其并发症，以及治疗糖尿病的潜在新方向。 2.为了支持新的研究人员，糖尿病研究领域的新老研究人员或 希望为他们的研究开创新方向的老牌糖尿病研究人员。 3.向包括芝加哥大学在内的整个芝加哥地区的研究人员征求P&F申请 芝加哥大学、西北大学、伊利诺伊大学芝加哥分校、伊利诺伊理工学院、 罗耀拉大学、罗莎琳德·富兰克林大学和威斯康星医学院。协作性 特别鼓励涉及不止一所大学的研究人员的项目。 P&F计划仍然是在整个芝加哥地区促进糖尿病研究的不可或缺的一部分 并极大地提高了DRTC计划在参与机构中的知名度。

PROJECT SUMMARY – PILOT & FEASIBILITY PROGRAM The Pilot & Feasibility Program (P&F) of the Chicago DRTC has funded more than 175 grants to more than 165 investigators since its inception in 1977. In the past 10 year reporting period, 46 applications were funded, including 27 from investigators located at affiliated institutions outside the University of Chicago. 34 of these 46 recipients (75%) received extramural funding as a result of P&F awards in the last 10 years, including 20 R01 awards, with a return on investment of nearly 10-fold. Thus, the P&F Program both assists investigators throughout the Chicago area in diabetes-related studies and also serves as a catalyst for obtaining new, independent funding from NIH and other extramural sources. The overall goal of the P&F Program is to provide initial support to newly established investigators and to bring the expertise of more established investigators from other fields into diabetes research. Proposals are sought each year from all Chicago-based institutions with diabetes research programs. All proposals are evaluated by an internal and two external reviewers. Priority scores and written reviews are then presented to the Steering Committee and funding decisions are made. A second year of funding is possible for those investigators who have made significant documented progress on their proposed research. All P&F grant recipients are required to attend and strongly encouraged to present their findings at the Annual Chicago Diabetes Day held at the University of Chicago or Diabetes & Obesity Research Day at the University of Illinois at Chicago. The vast majority of P&F grants recipients have remained in diabetes research. The Aims of the P&F Program are: 1. To fund P&F studies encompassing basic, translational, and clinical research into the causes of diabetes and its complications as well as potential new directions for the treatment of diabetes. 2. To support new investigators, established investigators new to the field of diabetes research or established diabetes researchers who wish to start a novel direction for their research. 3. To solicit P&F applications from researchers throughout the Chicagoland area, including the University of Chicago, Northwestern University, University of Illinois at Chicago, Illinois Institute of Technology, Loyola University, Rosalind Franklin University and the Medical College of Wisconsin. Collaborative projects involving researchers at more than one University are specifically encouraged. The P&F program remains an integral part of promoting diabetes research throughout the greater Chicago area and has greatly enhanced the visibility of the DRTC program at participating institutions.